• Application Note

Clozapine on Oasis MCX

Clozapine on Oasis MCX

  • Waters Corporation
Mental health issue; mental illness

Abstract

This application note highlights the separation of clozapine on Oasis MCX.

Introduction

Clozapine is used to treat schizophrenia in patients who have not been helped by or are unable to take other medicines. The analyte is basic and therefore an Oasis MCX product was selected.

Experimental

Test Conditions

Oasis MCX 10-mg 96-Well Plate

Condition:

500 μL MeOH

Equilibrate:

500 μL H2O

Load:

1 mL sample (500 μL human plasma diluted 1:1 with 4% H3PO4 in H2O)

Wash 1:

500 μL 2% HCOOH in H2O

Wash 2:

500 μL MeOH

Elute:

300 μL (150 μL x 2) 5% NH4OH in MeOH Dry and reconstitute w/100 μL 0.1% FA in H2O

Inject:

50 μL

Column:

SunFire C18 2.1 x 50 mm, 3.5 μm

Mobile Phase A:

0.1% FA in H2O

Mobile Phase B:

0.1% FA in MeOH

Flow Rate:

0.4 mL /min

Injection Volume:

50 μL

Instrument:

2777 Sample Manager and 1525μ Binary HPLC Pump

Quattro Premier

ESI+

Source Temp.:

150 °C

Desolvation Temp.:

350 °C

Cone Gas Flow:

50 L /Hr

Desolvation Gas Flow:

600 L /Hr

Collision Cell:

2.2e-3 bar (Ar gas)

Results and Discussion

Featured Products

WA60086, June 2007

Back To Top Back To Top